R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
Title | Location |
Date ![]() |
Req ID | |
---|---|---|---|---|
Specialist, Labelling & Compliance Regulatory Affairs, Global Rare Diseases
Parma, IT
Jul 11, 2024
4319
|
||||